Current and future trends in periodontal tissue engineering and bone regeneration

来源 :整形与美容研究(英文版) | 被引量 : 0次 | 上传用户:hdyear
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Periodontal tissue engineering involves a multi-disciplinary approach towards the regeneration of periodontal ligament, cementum and alveolar bone surrounding teeth, whereas bone regeneration specifically applies to ridge reconstruction in preparation for future implant placement, sinus floor augmentation and regeneration of peri-implant osseous defects. Successful periodontal regeneration is based on verifiable cementogenesis on the root surface, oblique insertion of periodontal ligament fibers and formation of new and vital supporting bone. Ultimately, regenerated periodontal and peri-implant support must be able to interface with surrounding host tissues in an integrated manner, withstand biomechanical forces resulting from mastication, and restore normal function and structure. Current regenerative approaches utilized in everyday clinical practice are mainly guided tissue/bone regeneration-based. Although these approaches have shown positive outcomes for small and medium-sized defects, predictability of clinical outcomes is heavily dependent on the defect morphology and clinical case selection. In many cases, it is still challenging to achieve predictable regenerative outcomes utilizing current approaches. Periodontal tissue engineering and bone regeneration (PTEBR) aims to improve the state of patient care by promoting reconstitution of damaged and lost tissues through the use of growth factors and signaling molecules, scaffolds, cells and gene therapy. The present narrative review discusses key advancements in PTEBR including current and future trends in preclinical and clinical research, as well as the potential for clinical translatability.
其他文献
Aim: We developed R lift, a modified en-bloc facelift, in response to growing demand for long-lasting, effective facelift procedures associated with minimal dow
1 临床资料rn1.1 病例特点rn患者,男,56岁,已婚,农民,主因“进行性言语障碍伴右侧肢体无力1 d”于2019年12月收住入院.查体:神志清楚,BP153/94 mmHg ,混合性失语,左侧肢体肌
期刊
目的:探讨凉血通瘀方对脑出血大鼠脑组织TLR4和NF-κB p65的影响。方法:24只SD健康雄性大鼠随机分成正常组、假手术组、模型组和凉血通瘀组,每组6只。模型组和凉血通瘀组采用注射泵控制器注血/二次退针法制作脑出血模型。造模成功后,凉血通瘀组给予凉血通瘀方水剂(1.0 mL/100 g)灌胃,每日1次;假手术组、模型组每日给予等剂量蒸馏水灌胃。各组灌胃3 d后进行大鼠行为学评分;Western Blot法测定Toll样受体4(TLR4)、核因子κB(NF-κB p65)蛋白表达变化;RT-PCR法检测
目的探讨Rho激酶(Rho-associated kinase,ROCK)抑制剂法舒地尔(Fasudil)对BV2小胶质细胞极化的影响。方法免疫荧光观察细胞形态及ROCK2表达水平;乳酸脱氢酶(Lactate dehydrogenase,LDH)细胞毒性检测试剂盒检测Fasudil对细胞的毒性作用;逆转录聚合酶链反应(Reverse transcription polymerase chain reaction,RT-PCR)检测小胶质细胞M1[CD86、肿瘤坏死因子α(Tumor necrosis fa
目的 探讨依达拉奉对缺血性脑卒中大鼠血管新生和神经发生的影响.方法 将SD大鼠分为对照组、缺血性脑卒中组、依达拉奉低剂量、高剂量组;后3组构建大脑中动脉闭塞/再灌注模型
目的探讨基质细胞衍生因子-1(Stromal cell-derived factor-1,SDF-1)/趋化因子受体7(Chemokine receptor 7,CXCR7)在脑梗死患者血清中的表达水平变化及其与颈动脉内膜中层厚度(Intima-media thickness,IMT)、斑块积分的相关性。方法选取2017年6月-2019年4月本院收治的186例脑梗死患者进行研究,称脑梗死组;并选取同期127例体检健康者进行对照研究,称对照组;比较2组一般资料;采用实时荧光定量PCR(Real-time f
缺血性脑卒中(Ischemic stroke ,IS)是目前威胁人类健康的重要疾病之一,IS后的能量消耗和缺氧状态可导致神经细胞坏死,从而激活驻留的神经胶质细胞并促进外周免疫细胞侵入至
期刊
目的探讨血管内皮生长因子(Vascular endothelial growth factor, VEGF)、细胞周期相关核抗原Ki-67抗体和p53的表达水平对脑膜瘤术后瘤周水肿(Pedtumoral brain edema, PTBE)的影响。方法选取2007年1月-2016年7月于本院就诊的脑膜瘤手术患者159例,采用免疫组化检测VEGF,Ki-67抗体和p53在159例脑膜瘤患者中的表达,应用磁共振成像(Magnetic resonance imaging, MRI)检查确定PTBE程度,其中术后
平山病(Hirayamadisease)是一种少见疾病,主要累及下运动神经元,常影响C7-T1脊髓神经及其支配的肌肉。该病在1959年由日本学者平山惠造首次报道,在临床上与已知的运动神经元病不同,该病以隐匿性发作为特征,男性多见,与人群有关,多在生命的第2个和第3个10年被诊断,大多患者有家族史,但散发性的报道也有。多数病例来源于亚洲国家,但在欧洲和美洲大陆也有报道。
目的分析视神经脊髓炎谱系疾病(Neuromyelitis optica spectrum disorders,NMOSDs)的临床特点,并探讨相关发病机制及诊治方案。方法回顾性收集2018年6月-2019年12月入住本院神经内科并诊断为NMOSDs的患者56例,分析患者的一般人口学特征、临床表现、实验室及影像学检查表现、诊疗及预后等。结果共纳入56例患者,男女比例为1∶10.2,首次发病年龄20~77(48.36±14.52)岁,73.2%患者表现为急性-亚急性起病,62.5%患者以急性脊髓炎起病,21.